Skip to main content
BSEM logo

BSEM · BioStem Technologies, Inc. · Debt

Track BSEM — free
$1.33 -0.18 (-11.92%) Q2 2026 earnings call transcript
Market Cap
$26.95M
Shares
17.85M
Volume · Oct 29 259.49K Avg daily vol (3M) 150.07K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Long-term debt, including current maturities 2026-06-30 USD 0 10-Q filed 2026-08-12
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current portion of notes payable
USD 1,000,000
Notes payable, including current maturities
USD 1,000,000
Operating lease liabilities 2026-06-30 USD 223,826 10-Q filed 2026-08-12
Related accounting measures — not additional borrowing

Carrying amounts can reflect issuance costs or discounts. Differences between these measures are not necessarily repayments due within a year.

Current operating lease liabilities
USD 222,471
Noncurrent operating lease liabilities
USD 1,355
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1658678 CUSIP 090684200 13F (30d) 2 filings 2 filers Visit website Investor relations